Everyday ScienceStudy raises possibility of immunotherapy treatment for ALS Posted on August 4, 2023September 10, 2023 by bricemarsters0 comments on “Study raises possibility of immunotherapy treatment for ALS” Continue reading "Study raises possibility of immunotherapy treatment for ALS"
Everyday SciencePancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers Posted on July 20, 2023September 14, 2023 by bricemarsters0 comments on “Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers” Continue reading "Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers"
Everyday ScienceReal-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer Posted on June 8, 2023June 7, 2023 by bricemarsters0 comments on “Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer” Continue reading "Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer"
Everyday ScienceAdding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence Posted on April 19, 2023April 18, 2023 by bricemarsters0 comments on “Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence” Continue reading "Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence"
Daily Dose Everyday ScienceDAILY DOSE: Is the moon about to become a massive billboard?; The era of psychedelic therapy is here. Posted on April 19, 2023April 19, 2023 by scientificinquirer0 comments on “DAILY DOSE: Is the moon about to become a massive billboard?; The era of psychedelic therapy is here.” Continue reading "DAILY DOSE: Is the moon about to become a massive billboard?; The era of psychedelic therapy is here."
Everyday Science Homo scientificus Rebel RebelREBEL REBEL TEMPLATE: William Bradley Coley and Coley’s Toxins was over a hundred years ahead of its time. Posted on March 30, 2023March 30, 2023 by scientificinquirer0 comments on “REBEL REBEL TEMPLATE: William Bradley Coley and Coley’s Toxins was over a hundred years ahead of its time.” Continue reading "REBEL REBEL TEMPLATE: William Bradley Coley and Coley’s Toxins was over a hundred years ahead of its time."
Everyday ScienceNew immunotherapy holds promise for ovarian cancer Posted on February 9, 2023February 8, 2023 by bricemarsters0 comments on “New immunotherapy holds promise for ovarian cancer” Continue reading "New immunotherapy holds promise for ovarian cancer"
Everyday ScienceSimultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients Posted on December 1, 2022December 1, 2022 by bricemarsters0 comments on “Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients” Continue reading "Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients"
Everyday ScienceThe exceptional case of a person who has survived 12 tumors opens up new avenues for early diagnosis and immunotherapy in cancers. Posted on November 8, 2022November 12, 2022 by bricemarsters0 comments on “The exceptional case of a person who has survived 12 tumors opens up new avenues for early diagnosis and immunotherapy in cancers.” Continue reading "The exceptional case of a person who has survived 12 tumors opens up new avenues for early diagnosis and immunotherapy in cancers."
Everyday ScienceAdvanced melanoma survival improves significantly when immunotherapy is given before targeted therapy Posted on September 28, 2022September 27, 2022 by bricemarsters0 comments on “Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy” Continue reading "Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy"